# CMV CTLs in Neonates With CMV Infection

> **NCT05564598** · PHASE2 · RECRUITING · sponsor: **New York Medical College** · enrollment: 23 (estimated)

## Conditions studied

- Congenital Cytomegaloviral (CMV) Disease

## Interventions

- **BIOLOGICAL:** CMV Cytotoxic T-Lymphocytes
- **DRUG:** Anti-viral Therapy

## Key facts

- **NCT ID:** NCT05564598
- **Lead sponsor:** New York Medical College
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-01
- **Primary completion:** 2027-10-31
- **Final completion:** 2028-10-31
- **Target enrollment:** 23 (ESTIMATED)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05564598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05564598, "CMV CTLs in Neonates With CMV Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05564598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*